Search
for
Sort by
Research 30 of 1000+
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats
- Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
- Hair loss in women with hyperandrogenism: Four cases responding to finasteride
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- Diagnosis of hyperandrogenism: clinical criteria
- MANAGEMENT OF ENDOCRINE DISEASE: Hyperandrogenism after menopause
- Diagnosis of hyperandrogenism: Biochemical criteria
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Treatment of hirsutism and acne in hyperandrogenism
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
- Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS
- Gonadotropin-Releasing Hormone Agonist Treatment in Postmenopausal Women with Hyperandrogenism of Ovarian Origin
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Prevalence of Hyperandrogenic States in Late Adolescent and Young Women: Epidemiological Survey on Italian High-School Students
- The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Psychological aspects of hyperandrogenic states in late adolescent and young women
- Manifestation of Hyperandrogenism in the Continuous Light Exposure-Induced PCOS Rat Model
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19